Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Atovaquon, ATC P01AX06
Description
This is not an open procedure, but an open-house model. The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded under the open-house model are not subject to public procurement law due to the lack of a selection decision. Using this form does not involve submission to public procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Atovaquon, ATC P01AX06, in accordance with § 130a, para. 8, SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible contract start date is 01.05.2026, and all contracts end on 30.04.2028. Contracts can be concluded at any time during this period, but at the latest by 03.03.2028. The contracts can be terminated with one month's notice to the end of the month. If a nationwide or regional discount contract for medicines with the subject matter of the contract comes into force, the open-house agreements will automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that prove their eligibility by completing and signing a self-declaration of reliability. The pharmaceutical company must submit the completed and signed (the signing authority of the signatory(s) must be evident from the commercial register extract, otherwise a power of attorney must be submitted) contract, together with the completed and signed annex "Specification of the contractual medicines" and the completed and signed self-declaration of reliability. The documents can be submitted EITHER IN WRITING, signed by hand OR ELECTRONICALLY with a qualified electronic signature. Documents signed by hand in writing must be sent in duplicate original to the following address: AOK Bayern - Die Gesundheitskasse Vergabestelle SGB V ZE25 open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature must be submitted via the communication section in the tendering portal www.dtvp.de. If complete and correct documents are received by the 03rd of each month, the contract will commence on the first of the following month, otherwise on the first of the month after next. For documents signed by hand in writing, the complete, filled-out and signed documents must be sent in advance as a scan to the email address [email protected] or via the communication section in the tendering portal www.dtvp.de in a timely manner, if the complete and correct original documents in paper form are received by AOK Bayern, Vergabestelle, by the 10th of the month. Please note the completion instructions, which are available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered as potential contracting partners. The documents of the open-house procedure will be released exclusively to pharmaceutical companies as potential contracting partners and must be treated as strictly confidential. By requesting the release by the companies, the confidential treatment of the documents is confirmed.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical consumables – Rahmenvergabe für die Lieferleistung von medizinischen Produkten für den operativen Rettungsdienst der Feuerwehr Hannover für den Zeitraum für den Zeitraum vom 01.12.2026 bis 29.11.2030
Landeshauptstadt Hannover - Fachbereich FeuerwehrGermanyMedical consumablesMedical equipments, pharmaceuticals and personal care productsMedical equipmentsDeadline in 28 daysPublished on Sep 13, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Infliximab, ausgenommen in der Wirkstärke 120mg, ATC L04AB02
AOK Bayern - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 720 daysPublished on Sep 13, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Raloxifen, ATC G03XC01
AOK Bayern - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 720 daysPublished on Sep 13, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Infliximab, in der Wirkstärke 120mg, ATC L04AB02
AOK Bayern - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 720 daysPublished on Sep 13, 2026